Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,302 | 65,860 | 58,838 | 70,105 | 47,918 |
| Receivables | 109 | 2,879 | 6,937 | 1,516 | 2,283 |
| Other current assets | 2,515 | 1,943 | 1,692 | 919 | 1,801 |
| TOTAL | $121,926 | $70,682 | $67,467 | $72,540 | $52,002 |
| Non-Current Assets | |||||
| PPE Net | 2,552 | 2,413 | 3,399 | 4,038 | 5,878 |
| Investments And Advances | 0 | 2,208 | 3,240 | 3,332 | 3,608 |
| Intangibles | 36,402 | 39,081 | 0 | 0 | 0 |
| Other Non-Current Assets | 157 | 157 | 2,202 | 200 | 1,250 |
| TOTAL | $39,111 | $43,859 | $8,841 | $7,570 | $10,736 |
| Total Assets | $161,037 | $114,541 | $76,308 | $80,110 | $62,738 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,570 | 6,512 | 5,640 | 6,331 | 9,683 |
| Other current liabilities | 115 | 115 | 115 | 115 | 112 |
| TOTAL | $6,685 | $6,627 | $8,662 | $6,650 | $9,795 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 838 | 204 | N/A |
| Other Non-Current Liabilities | 18,111 | 16,614 | 1,078 | 1,497 | 1,635 |
| TOTAL | $29,443 | $28,935 | $1,078 | $1,659 | $1,635 |
| Total Liabilities | $36,128 | $35,562 | $9,740 | $8,309 | $11,430 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,640 | 69,575 | 51,131 | 33,862 | 33,362 |
| Common Shares | 91 | 79 | 61 | 44 | 43 |
| Retained earnings | -462,267 | -466,677 | -424,105 | -388,674 | -399,055 |
| Other shareholders' equity | 259 | 67 | -1 | -9 | -33 |
| TOTAL | $124,909 | $78,979 | $66,568 | $71,801 | $51,308 |
| Total Liabilities And Equity | $161,037 | $114,541 | $76,308 | $80,110 | $62,738 |